Risk factors and seroprevalence of hepatitis C antibody in blood donors in Nigeria

East African Medical Journal

Volumn 77, Issue 8, 2000, Pages 410-412

  Halim, N K D ^a   Ajayi, O I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; BLOOD; BLOOD DONOR; EPIDEMIOLOGY; FEMALE; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; NIGERIA; RISK FACTOR; STATISTICS;

ADULT; BLOOD DONORS; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; NIGERIA; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 0034340465     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Esteban J.I., Gonzalez A. and Hernandez J.M., et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion associated hepatitis. N. Engl. J. Med. 1990; 323:1107-12.
2. Esteban J.I., Esteban R., Viladomiu I., et al. Hepatitis virus antibodies among risk groups in Spain. Lancet. 1989; 2:294-7.
3. Alter H.J., Purcell R.H. and Shih J.W. et al. Detection of antibody to hepatitis C Virus in prospectively followed transfusion recipients with acute and chronic non - A, non - B hepatitis. N. Engl. J. Med. 1989; 321:1494-500.
4. Hopf. U., Moller. B. and Kuther D., et al. Long-term follow-up of post transfusion and sporadic non - A, non - B chronic hepatitis and frequency of circulating antibodies to hepatitis C virus (HCV) J. Hepatol. 1990; 10:69-76.
5. Kuo G., Choo Q.L. and Alter H.J. et al. An assay for circulating antibodies to a major aetiologic virus of human non - A, non-B hepatitis. Science. 1989; 244:362-4.
6. Alter M.J., Hadler S.C., Judson F.N. et al. Risk factors for acute non - A, non - B hepatitis in the United States and association with hepatitis C virus infection. J. Amer. Med. Ass. 1990; 264:2231-5.
7. Mosley J.W., Aach R.D. and Hollinger F.B. et al. Non-A, non-B hepatitis and antibody to hepatitis C virus. J. Amer. Med. Ass. 1990; 263:77-8.
8. Dienstag J.L. Non-A., non-B hepatitis. Recognition, epidemiology and clinical features. Gastroenterology. 1983; 85:439-62.
9. Mutimer V.J., Olomu A., Skidmore S. and Olomu N., et al. Viral hepatitis in Nigeria - Sickle - Cell disease and commercial blood donors. Quart. J. Med. 1994; 87: 407-411.
10. Darwish M.A., Tahani A.R., Rushdy P. and Constantine T.N. et al. Risk Factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian Blood donors. Amer. J. trop. Med. Hyg. 1993; 49:440-447.
11. Frommel D., Tekle - Halmanot R., Behre N. and Aussel L. et al. A survey of antibodies to hepatitis C. virus in Ethiopia. Amer. J. trop. Med. Hyg. 1993; 49:435-439.
12. Scott D.A., Contantine N.T., Callahan J., Burans J.P. et al. The epidemiology of hepatitis C virus antibody in Yemen. Amer. J. trop. Med Hyg. 1992; 46:63-68.
13. Craig P.G., Bryan. J.P., Miller. R.E. and Reyes L. et al. The prevalence of hepatitis A, B and C infection among different ethnic groups in Belize. Amer. J. trop. Med. Hyg. 1993; 49:430-43.
14. Janot C., Courouce A.M. and Maniez M. Antibodies to hepatitis C virus in French blood donors. Lancet. 1989; 2:796-797.
15. Sirchia G., Belloubuono A., Giovanetti., Marconi M. Antibodies to hepatitis C virus in Italian Blood donors. Lancet ii:797.
16. Halim N.K.D., Offor E., Ajayi O.I. Hepatitis B surface antigen (HBs Ag): Epidemiological and seroprevalence studies. Afr. J. Med. Pract. 1998; 5:239.
17. Tanaka E., Kigosawa K., Sodeyama T., Hayata T. et al. Prevalence of antibody to hepatitis C virus in Japanese school children: Comparison with adult blood donors. Amer. J. trop. Med. 1992; 46:460-464.
18. Kuhnl P., Seldl S., Stangel W. and Beyer J. et al. Antibody to hepatitis C virus in German blood donors. Lancet. 1989; ii: 324.
19. Kelen G.D., Green G.B., Purcell R.H. Chan D.W. et al. Hepatitis B and hepatitis C in emergency department patients. N. Engl. J. med. 1992; 326:1399-404.
20. Briux J., Barrera J.M., Calvet X. and Ercilla G. et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. 1989; 2:1004-1006.